GPX4 and neoplasm: It is noteworthy that CD8+ T cells are significantly more sensitive to GPX4 inhibition than tumor cells: ACSL4 knockdown significantly reduces ferroptotic cell death, while FSP1 overexpression provides protection through the CoQ10 regeneration pathway (156).